Akèy › Limfòm selil-T kutane › Massachusetts › Boston
Etid klinik pou Limfòm selil-T kutane nan Boston, MA
5 etid pou Limfòm selil-T kutane ap chèche patisipan nan sit nan ak bò kote Boston (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma
Ap rekriteFaz 1
- Beth Israel Deaconess Medical Center - Research, Boston
A Phase 2 Study of PTX 100 in Patients With Relapsed/Refractory CTCL
Ap rekriteFaz 2
- Dana-Farber Cancer Institute, Boston
A Pilot of a Microdevice For In Situ Candidate Drug Screening in Cutaneous Lesions of T-Cell Lymphoma
Ap rekrite
- Dana Farber Cancer Institute, Boston
Pembrolizumab and Brentuximab Vedotin in Subjects With Relapsed/Refractory T-cell Lymphoma
Ap rekriteFaz 2
- Dana Farber Cancer Institute, Boston
A Registry for People With T-cell Lymphoma
Ap rekriteEtid obsèvasyon
- Massachusetts General Hospital (Data Collection Only), Boston
- Dana Farber Cancer Institute (Data Collection Only), Boston
Etid Limfòm selil-T kutane nan lòt vil
- New York City, NY9 etid
- Baldwin Park, CA8 etid
- Houston, TX5 etid
- New Haven, CT4 etid
- Chicago, IL3 etid
- Ann Arbor, MI3 etid
- Scottsdale, AZ3 etid
- Durham, NC3 etid
- Tampa, FL3 etid
- Columbus, OH3 etid
- Rochester, MN3 etid
Lòt etid nan Boston
- Kansè nan tete111 etid
- Kansè Poumon ki pa ti selil90 etid
- Kansè (tout kalite)86 etid
- Kansè kolorektal63 etid
- Kansè Metastatik63 etid
- Kansè poumon62 etid
- Kansè ovè61 etid
- Kansè pwostat59 etid
- Depresyon52 etid
- Kansè Endomèt50 etid
- Ensifizyans kadyak44 etid
- Leksemi mieloïd egi44 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.